Repositorio Dspace

Listar por tema "Tenofovir/therapeutic use"

Listar por tema "Tenofovir/therapeutic use"

Ordenar por:Orden:Resultados:

  • Longitudinal changes in circulating biomarkers from baseline to week 48 in treatment-Naïve people living with HIV initiating integrase inhibitor-based antiretroviral therapy 
    Blanco, José-Ramón; Torralba, Miguel; Saumoy, María; Alcaraz, Antonia; Matarranz-del-Amo, Mariano; Olalla, Julián; Dronda, Fernando; Boukichou-Abdelkader, Nisa; Bernal-Morell, Enrique; Padilla, Sergio; Peraire, Joaquim; Artigues, Francisca; Bustinduy-Odriozola, María-Jesús; Algendin-Iglesias, Helena; Delgado, Alberto; Imaz, Arkaitz; Pérez-Martínez, Laura; Cohort, Cor.-I.-S (PUBLIC LIBRARY SCIENCE, 2026-02-18)
    BACKGROUND: Currently, integrase strand-transfer inhibitors (INSTIs) are the cornerstone of antiretroviral therapy (ART), providing potent viral suppression and good tolerability. Emerging evidence suggests that INSTI-based ...
  • Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort 
    Berenguer, Juan; Díez, Cristina; Martín-Vicente, María; Mican, Rafael; Pérez-Elias, María-Jesús; García-Fraile, Lucio-Jesús; Vidal, Francisco; Suárez-García, Inés; Podzamczer, Daniel; del-Romero, Jorge; Pulido, Federico; Iribarren, José-Antonio; Gutiérrez, Félix; Poveda, Eva; Galera, Carlos; Izquierdo, Rebeca; Asensi, Víctor; Portilla, Joaquín; López, Juan-C; Arribas, José-R; Moreno, Santiago; González-García, Juan; Resino, Salvador; Jarrin, Inmaculada (ELSEVIER SCI LTD, 2021-11)
    OBJECTIVES: We aimed to assess the prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and factors associated with seropositivity and asymptomatic coronavirus disease 2019 (COVID-19) among people ...